Results 11 to 20 of about 80,912 (259)

Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis

Journal of the Formosan Medical Association, 2022
Background/Purpose: Orthokeratology (Ortho-K), atropine eye drops and combined atropine with Ortho-K are proven to be effective ways to prevent myopic progression in many studies, but there is scarce evidence regarding the comparative efficacy of ...
Cheng Jen, Jen-Hung Wang, Tai-Li Chen
exaly   +3 more sources

Antiherpesvirus action of atropine [PDF]

Antimicrobial Agents and Chemotherapy, 1984
The antimuscarinic compound atropine shows an antiherpesvirus effect as measured by the protection of the cell monolayer and the reduction of the formation of new infectious virus. Atropine at a concentration of 200 micrograms/ml blocks the production of new infectious herpes simplex virus-type 1 virions.
Alarcón, Balbino, González, María Eugenia, Carrasco, Luis   +2 more
openaire   +4 more sources

A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine

PLoS ONE, 2023
PurposeTo evaluate the efficacy of a myopia control spectacle lens (DIMS) at slowing the progression of myopia in a population of European children in comparison with 0.01% atropine and combined DIMS and atropine.MethodsThe study was a non-randomised ...
Paolo Nucci, Rakhee Shāh, Bruce Jw Evans   +2 more
exaly   +3 more sources

Retardation of myopia by atropine regimes [PDF]

International Journal of Ophthalmology
Myopia is a huge health problem due to its high frequency, vision losses and public health cost. According to the World Health Organization, at least 2.2 billion people have vision impairment.
Qin Zhu, Li Chen, Jia-Rui Liang, Min Hu, Li-Ping Xue, Guang-Long Zhou, Yuan Zhou, Jie-Ying Zhang, David Fernandez-Hazoury, Allison Helman, Ying-Ting Zhu, Xiao-Fan Zhang   +11 more
doaj   +3 more sources

Network pharmacology and molecular dynamics simulations reveal shared mechanisms and myopia-specific targets of atropine in myopia and dry eye disease [PDF]

Eye and Vision
Background Atropine is an effective agent for myopia control; however, clinical reports have indicated potential side effects associated with inducing or exacerbating dry eye disease (DED).
Meng Lin, Wanyi Shu, Guo Hua, Zhikang Duan, Jia Qu, Liang Hu   +5 more
doaj   +2 more sources

The Effect of Low-Dose Atropine on Alpha Ganglion Cell Signaling in the Mouse Retina

Frontiers in Cellular Neuroscience, 2021
Low-dose atropine helps to control myopia progression with few side effects. However, the impact of atropine, a non-selective muscarinic Acetylcholine (ACh) receptor antagonist, on retinal ganglion cells (RGCs) remains unclear. After immersing the cornea
Qin Wang, Seema Banerjee, ChungHim So, ChunTing Qiu, YingHon Sze, Thomas Chuen Lam, Thomas Chuen Lam, Chi-Ho To, Chi-Ho To, Feng Pan, Feng Pan   +10 more
doaj   +1 more source

Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis

Frontiers in Medicine, 2022
Purpose: To evaluate the efficacy and safety of atropine for slowing myopia progression and to investigate whether the treatment effect remains constant with continuing treatment.Method: Studies were retrieved from MEDLINE, EMBASE, and the Cochrane ...
Jiahe Gan, Jiahe Gan, Shi-Ming Li, Shi-Ming Li, Shanshan Wu, Kai Cao, Kai Cao, Dandan Ma, Dandan Ma, Xi He, Xi He, Ziyu Hua, Ziyu Hua, Meng-Tian Kang, Meng-Tian Kang, Shifei Wei, Shifei Wei, Weiling Bai, Weiling Bai, Ningli Wang, Ningli Wang   +20 more
doaj   +1 more source

Stability and Sterility of Extemporaneously Prepared 0.01% Atropine Ophthalmic Solution in Artificial Tears and Balanced Salt Solution

Siriraj Medical Journal, 2022
Objective: The aim of this study was to investigate the physicochemical and microbiological stability of extemporaneously prepared 0.01% atropine ophthalmic solution in unopened eyedropper and in simulated use condition.
Jureeporn Sri-in, Waraphorn Sisan, Phonphailin Kingkhangphloo, Pinpilai Jutasompakorn, Weerawadee Chandranipapongse, Somruedee Chatsiricharoenkul, Onchira Buranakan, Arpha Pornseth, Thammanoon Surachatkumtonekul   +8 more
doaj   +1 more source

0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial [PDF]

International Journal of Ophthalmology, 2023
AIM: To evaluate the effect of 0.05% atropine on the control of myopia for 2y (phase I) and on spherical equivalent refraction (SER) progression for 1y (phase II) after its withdrawal in Chinese myopic children.
Qin Zhu, Guang-Yong Tang, Zhi-Juan Hua, Li-Ping Xue, Yuan Zhou, Jie-Ying Zhang, Ying-Ting Zhu, Xiao-Fan Zhang   +7 more
doaj   +1 more source

Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants

BMC Research Notes, 2022
Objective As low-dose atropine eye-drops for myopia progression control prepared in-house by diluting the commercial 0.1% atropine eye-drop with sterile water or normal saline has been a common practice whereas atropine injection is readily available and
Nuthida Wongwirawat, Nirachorn Kuchonthara, Sorrawit Boontanomwong, Krit Pongpirul   +3 more
doaj   +1 more source